Table 5.
Symptom burden | |||||
---|---|---|---|---|---|
Group | Low (n = 42) | High (n = 88) | P* | ||
n | % | n | % | ||
Treatment | |||||
Radiotherapy** | 23 | 56.10 | 29 | 33.72 | .017 |
Chemoradiotherapy** | 18 | 43.90 | 57 | 66.28 | |
Age | |||||
< 60 years | 26 | 61.90 | 35 | 39.77 | .018 |
≥ 60 years | 16 | 38.10 | 53 | 60.23 | |
Sex | |||||
Women | 13 | 30.95 | 19 | 21.59 | .247 |
Men | 29 | 69.05 | 69 | 78.41 | |
Tumor stage | |||||
0/I/II | 32 | 86.49 | 52 | 62.65 | .009 |
III/IV | 5 | 13.51 | 31 | 37.35 | |
Cancer site | |||||
Pharynx | 20 | 48.78 | 42 | 47.73 | .894 |
Tongue | 1 | 2.44 | 22 | 25.00 | .002 |
ECOG PS | |||||
0 | 36 | 92.31 | 52 | 60.47 | .0003 |
≥ 1 | 3 | 7.69 | 34 | 39.53 | |
Total radiation dose | |||||
≤ 60 Gy | 30 | 71.43 | 51 | 58.62 | .159 |
> 60 Gy | 12 | 28.57 | 36 | 41.38 |
Chi square test